- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | UCB's Bimzelx takes top drug ad spending spot as streaming data come to the fore | ||
| Mo | AI, Data and the New Rules of HCP Marketing | ||
| Mo | How Ohio Is Building a Biopharma Growth Engine | ||
| Mo | AI-Powered Brand Sites Are Changing Patient Engagement | ||
| Mo | Why Medical Teams Must Lead DOL Strategy | ||
| Mo | RevHealth's Chris Cullmann on AI and Human-Centered Pharma | ||
| Mo | How Predictive Modeling Uncovers Blind Spots in the Patient Journey | ||
| Mo | Why AI's Biggest Value in Pharma Is Confidence | ||
| Mo | Executive Interviews at Fierce Pharma Week 2026 | ||
| Mo | Fullspan Health on Winning the AI Search Revolution | ||
| Mo | Why AI and Precision Matter in Pharma Commercialization | ||
| Mo | Beyond the Pharmacy Counter: Inmar's Data Advantage | ||
| Mo | Beyond Data: Understanding the "Why" Behind HCP Decisions | ||
| Mo | Why MRC Accreditation Is Just the First Step | ||
| Mo | Why Medical Affairs Is Becoming Biopharma's Third Pillar | ||
| Mo | From Data Rich to Decision Ready in Life Sciences | ||
| Fr | GSK commits $800M to R&D, manufacturing hub, as Pennsylvania bonds deepen | ||
| Fr | Quince Therapeutics relaunches as IRulya, going all in on lung disease after Hail Mary merger | ||
| Fr | FDA's Rasonque review documents pressure RevMed as investors jitter over KRAS subgroup data | ||
| Fr | Teva debuts Weltruza in schizophrenia as much-hyped FDA nod for long-acting olanzapine arrives | ||
| Fr | Fierce Pharma Asia-Novartis' $7.8B mRNA deal; Shionogi's $2B buy; ArriVent's phase 3 flop | ||
| Fr | Pharma's free lunches for clinicians bloat prescription bills: Cochrane review | ||
| 08.10. | BMS fills out Zenbexus picture with post-approval PFS victory in multiple myeloma | ||
| 08.10. | Viatris to snap up Pacira's non-opioid pain pipeline for $1.65B | ||
| 08.10. | Pfizer's Tukysa snags first-line approval in HER2+ breast cancer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.